These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. I. Preliminary characteristics. Hanicki Z, Sarnecka-Keller M, Klein A, Slizowska K. Clin Chim Acta; 1974 Jul 15; 54(1):47-54. PubMed ID: 4847123 [No Abstract] [Full Text] [Related]
3. Many hitherto unknown peptides are principal constituents of uremic "middle molecules". Menyhárt J, Gróf J. Clin Chem; 1981 Oct 15; 27(10):1712-6. PubMed ID: 7285323 [Abstract] [Full Text] [Related]
4. Separation, isolation and amino acid composition of uremic peptides. Shaykh M, Dubin A, Dunea G, Mamdani B, Ahmed S. Clin Physiol Biochem; 1984 Oct 15; 2(1):1-13. PubMed ID: 6488692 [Abstract] [Full Text] [Related]
9. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation]. Buzio C, Dall'Aglio PP, Delmonte G, Montagna G, Migone L. Minerva Nefrol; 1979 Mar 18; 26(1):45-8. PubMed ID: 471320 [No Abstract] [Full Text] [Related]
11. Low molecule and middle molecule metabolites with haemodynamic activity in the ultrafiltrate from uraemic patients (author's transl). Pogglitsch H, Petek W, Waller J, Stübchen-Kirchner H. Wien Klin Wochenschr; 1977 Dec 23; 89(24):812-9. PubMed ID: 595605 [Abstract] [Full Text] [Related]
13. Isolation of the homogeneous constituents from non-diffusible sugar-peptide (NSP) fraction originating from bovine plasma. III. The method of isolation and partial characterization of the four peptide constituents. Klein A. Folia Histochem Cytochem (Krakow); 1983 Dec 23; 21(1):3-14. PubMed ID: 6873768 [Abstract] [Full Text] [Related]
15. Comparative studies on the nonprotein but nondialysable sugar-peptide fraction isolated from the plasma of various classes of vertebrates. Turyna I, Turyna B, Sarnecka-Keller M. Comp Biochem Physiol B; 1977 Dec 23; 56(4):403-6. PubMed ID: 318251 [Abstract] [Full Text] [Related]
16. Middle molecules in uremic serum, urine and dialysis fluid. Migone L, Dall'taglio P, Buzio C. Clin Nephrol; 1975 Dec 23; 3(3):82-93. PubMed ID: 1139803 [Abstract] [Full Text] [Related]
18. Molecular weight distribution, diffusibility and comparability of middle molecular fractions prepared from normal and uremic sera by different fractionation procedures. Gróf J, Menyhárt J. Nephron; 1982 Dec 23; 30(1):60-7. PubMed ID: 7088233 [Abstract] [Full Text] [Related]
19. Non diffusible toxic polypeptides in uraemic sera: a new group of uraemic toxins. Gróf J, Menyhárt J. Acta Chir Acad Sci Hung; 1977 Dec 23; 18(3):283-7. PubMed ID: 605725 [Abstract] [Full Text] [Related]
20. Uraemic toxins of high molecular weight inhibiting human mononuclear phagocytes cultured in vitro. Jörstad S, Kvernes S. Acta Pathol Microbiol Scand C; 1978 Oct 23; 86C(5):221-6. PubMed ID: 362814 [Abstract] [Full Text] [Related] Page: [Next] [New Search]